These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
546 related articles for article (PubMed ID: 18948646)
21. Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma. Tunici P; Bissola L; Lualdi E; Pollo B; Cajola L; Broggi G; Sozzi G; Finocchiaro G Mol Cancer; 2004 Oct; 3():25. PubMed ID: 15469606 [TBL] [Abstract][Full Text] [Related]
22. Evidence for cancer stem cells in human endometrial carcinoma. Hubbard SA; Friel AM; Kumar B; Zhang L; Rueda BR; Gargett CE Cancer Res; 2009 Nov; 69(21):8241-8. PubMed ID: 19843861 [TBL] [Abstract][Full Text] [Related]
23. An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours. Fael Al-Mayhani TM; Ball SL; Zhao JW; Fawcett J; Ichimura K; Collins PV; Watts C J Neurosci Methods; 2009 Jan; 176(2):192-9. PubMed ID: 19215724 [TBL] [Abstract][Full Text] [Related]
24. Identification of cancer stem cells in dog glioblastoma. Stoica G; Lungu G; Martini-Stoica H; Waghela S; Levine J; Smith R Vet Pathol; 2009 May; 46(3):391-406. PubMed ID: 19176492 [TBL] [Abstract][Full Text] [Related]
25. Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Ikushima H; Todo T; Ino Y; Takahashi M; Miyazawa K; Miyazono K Cell Stem Cell; 2009 Nov; 5(5):504-14. PubMed ID: 19896441 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA and stem cell regulation. Wang Y; Russell I; Chen C Curr Opin Mol Ther; 2009 Jun; 11(3):292-8. PubMed ID: 19479662 [TBL] [Abstract][Full Text] [Related]
27. Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma. Favaro R; Appolloni I; Pellegatta S; Sanga AB; Pagella P; Gambini E; Pisati F; Ottolenghi S; Foti M; Finocchiaro G; Malatesta P; Nicolis SK Cancer Res; 2014 Mar; 74(6):1833-44. PubMed ID: 24599129 [TBL] [Abstract][Full Text] [Related]
28. Landscape of the SOX2 protein-protein interactome. Fang X; Yoon JG; Li L; Tsai YS; Zheng S; Hood L; Goodlett DR; Foltz G; Lin B Proteomics; 2011 Mar; 11(5):921-34. PubMed ID: 21280222 [TBL] [Abstract][Full Text] [Related]
29. Deregulated microRNAs identified in isolated glioblastoma stem cells: an overview. Chu PM; Ma HI; Chen LH; Chen MT; Huang PI; Lin SZ; Chiou SH Cell Transplant; 2013; 22(4):741-53. PubMed ID: 23127968 [TBL] [Abstract][Full Text] [Related]
30. Primary glioblastomas express mesenchymal stem-like properties. Tso CL; Shintaku P; Chen J; Liu Q; Liu J; Chen Z; Yoshimoto K; Mischel PS; Cloughesy TF; Liau LM; Nelson SF Mol Cancer Res; 2006 Sep; 4(9):607-19. PubMed ID: 16966431 [TBL] [Abstract][Full Text] [Related]
31. Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells. Lopez-Bertoni H; Lal B; Michelson N; Guerrero-Cázares H; Quiñones-Hinojosa A; Li Y; Laterra J Oncogene; 2016 Sep; 35(37):4903-13. PubMed ID: 26898758 [TBL] [Abstract][Full Text] [Related]
32. Identification of tumor stem-like cells in a mouse myeloma cell line. Dou J; Li Y; Zhao F; Hu W; Wen P; Tang Q; Chu L; Wang Y; Cao M; Jiang C; Gu N Cell Mol Biol (Noisy-le-grand); 2009 Aug; 55 Suppl():OL1151-60. PubMed ID: 19656468 [TBL] [Abstract][Full Text] [Related]
33. Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation. Berezovsky AD; Poisson LM; Cherba D; Webb CP; Transou AD; Lemke NW; Hong X; Hasselbach LA; Irtenkauf SM; Mikkelsen T; deCarvalho AC Neoplasia; 2014 Mar; 16(3):193-206, 206.e19-25. PubMed ID: 24726753 [TBL] [Abstract][Full Text] [Related]
34. EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme. Day BW; Stringer BW; Al-Ejeh F; Ting MJ; Wilson J; Ensbey KS; Jamieson PR; Bruce ZC; Lim YC; Offenhäuser C; Charmsaz S; Cooper LT; Ellacott JK; Harding A; Leveque L; Inglis P; Allan S; Walker DG; Lackmann M; Osborne G; Khanna KK; Reynolds BA; Lickliter JD; Boyd AW Cancer Cell; 2013 Feb; 23(2):238-48. PubMed ID: 23410976 [TBL] [Abstract][Full Text] [Related]
35. BMPing off glioma stem cells. Nakano I; Saigusa K; Kornblum HI Cancer Cell; 2008 Jan; 13(1):3-4. PubMed ID: 18167333 [TBL] [Abstract][Full Text] [Related]
36. Glioblastoma tumor initiating cells: therapeutic strategies targeting apoptosis and microRNA pathways. Liu J; Albrecht AM; Ni X; Yang J; Li M Curr Mol Med; 2013 Mar; 13(3):352-7. PubMed ID: 23331007 [TBL] [Abstract][Full Text] [Related]
37. Aberrant Notch signaling in glioblastoma stem cells contributes to tumor recurrence and invasion. Yu JB; Jiang H; Zhan RY Mol Med Rep; 2016 Aug; 14(2):1263-8. PubMed ID: 27315154 [TBL] [Abstract][Full Text] [Related]
38. Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity? Lemke D; Weiler M; Blaes J; Wiestler B; Jestaedt L; Klein AC; Löw S; Eisele G; Radlwimmer B; Capper D; Schmieder K; Mittelbronn M; Combs SE; Bendszus M; Weller M; Platten M; Wick W J Neurochem; 2014 Oct; 131(2):251-64. PubMed ID: 24976529 [TBL] [Abstract][Full Text] [Related]
39. Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Ghods AJ; Irvin D; Liu G; Yuan X; Abdulkadir IR; Tunici P; Konda B; Wachsmann-Hogiu S; Black KL; Yu JS Stem Cells; 2007 Jul; 25(7):1645-53. PubMed ID: 17412894 [TBL] [Abstract][Full Text] [Related]
40. Cancer stem cells and glioma. Das S; Srikanth M; Kessler JA Nat Clin Pract Neurol; 2008 Aug; 4(8):427-35. PubMed ID: 18628751 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]